New Hampshire Trust Bristol Myers Squibb CO Transaction History
New Hampshire Trust
- $437 Billion
- Q1 2025
A detailed history of New Hampshire Trust transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, New Hampshire Trust holds 10,125 shares of BMY stock, worth $617,523. This represents 0.14% of its overall portfolio holdings.
Number of Shares
10,125
Previous 10,095
0.3%
Holding current value
$617,523
Previous $571 Million
8.15%
% of portfolio
0.14%
Previous 0.12%
Shares
9 transactions
Others Institutions Holding BMY
# of Institutions
2,772Shares Held
1.56BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.68 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.86 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.8 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.68 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $130B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...